-
1
-
-
84924418925
-
Anemia: progress in molecular mechanisms and therapies
-
Sankaran VG, Weiss MJ. Anemia: progress in molecular mechanisms and therapies. Nat Med. 2015;21(3):221-30. doi: 10.1038/nm.3814.
-
(2015)
Nat Med
, vol.21
, Issue.3
, pp. 221-230
-
-
Sankaran, V.G.1
Weiss, M.J.2
-
2
-
-
42949127743
-
Anaemia of cancer: an overview of mechanisms involved in its pathogenesis
-
Grotto HZ. Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Med Oncol. 2008;25(1):12-21. doi: 10.1007/s12032-007-9000-8.
-
(2008)
Med Oncol
, vol.25
, Issue.1
, pp. 12-21
-
-
Grotto, H.Z.1
-
3
-
-
5344263788
-
The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients
-
Ludwig H, Van Belle S, Barrett-Lee P, Birgegard G, Bokemeyer C, Gascon P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004;40(15):2293-306. doi: 10.1016/j.ejca.2004.06.019.
-
(2004)
Eur J Cancer
, vol.40
, Issue.15
, pp. 2293-2306
-
-
Ludwig, H.1
Belle, S.2
Barrett-Lee, P.3
Birgegard, G.4
Bokemeyer, C.5
Gascon, P.6
-
4
-
-
33644862202
-
Iron imports. IV. Hepcidin and regulation of body iron metabolism
-
Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol. 2006;290(2):G199-203. doi: 10.1152/ajpgi.00412.2005.
-
(2006)
Am J Physiol Gastrointest Liver Physiol
, vol.290
, Issue.2
, pp. G199-203
-
-
Ganz, T.1
Nemeth, E.2
-
5
-
-
84885768132
-
Systemic iron homeostasis
-
Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93(4):1721-41. doi: 10.1152/physrev.00008.2013.
-
(2013)
Physiol Rev
, vol.93
, Issue.4
, pp. 1721-1741
-
-
Ganz, T.1
-
6
-
-
33750133047
-
Regulation of iron metabolism by hepcidin
-
Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr. 2006;26:323-42. doi: 10.1146/annurev.nutr.26.061505.111303.
-
(2006)
Annu Rev Nutr
, vol.26
, pp. 323-342
-
-
Nemeth, E.1
Ganz, T.2
-
7
-
-
35648995976
-
Interleukin-6 and its receptor in cancer: implications for translational therapeutics
-
Hong DS, Angelo LS, Kurzrock R. Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer. 2007;110(9):1911-28. doi: 10.1002/cncr.22999.
-
(2007)
Cancer
, vol.110
, Issue.9
, pp. 1911-1928
-
-
Hong, D.S.1
Angelo, L.S.2
Kurzrock, R.3
-
8
-
-
22044438662
-
Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia
-
Maccio A, Madeddu C, Massa D, Mudu MC, Lusso MR, Gramignano G, et al. Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia. Blood. 2005;106(1):362-7. doi: 10.1182/blood-2005-01-0160.
-
(2005)
Blood
, vol.106
, Issue.1
, pp. 362-367
-
-
Maccio, A.1
Madeddu, C.2
Massa, D.3
Mudu, M.C.4
Lusso, M.R.5
Gramignano, G.6
-
9
-
-
0029096426
-
Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients
-
Nieken J, Mulder NH, Buter J, Vellenga E, Limburg PC, Piers DA, et al. Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients. Blood. 1995;86(3):900-5.
-
(1995)
Blood
, vol.86
, Issue.3
, pp. 900-905
-
-
Nieken, J.1
Mulder, N.H.2
Buter, J.3
Vellenga, E.4
Limburg, P.C.5
Piers, D.A.6
-
10
-
-
33751175421
-
Interleukin-6 induces hepcidin expression through STAT3
-
Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108(9):3204-9. doi: 10.1182/blood-2006-06-027631.
-
(2006)
Blood
, vol.108
, Issue.9
, pp. 3204-3209
-
-
Wrighting, D.M.1
Andrews, N.C.2
-
11
-
-
47049116150
-
Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha
-
Pinto JP, Ribeiro S, Pontes H, Thowfeequ S, Tosh D, Carvalho F, et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood. 2008;111(12):5727-33. doi: 10.1182/blood-2007-08-106195.
-
(2008)
Blood
, vol.111
, Issue.12
, pp. 5727-5733
-
-
Pinto, J.P.1
Ribeiro, S.2
Pontes, H.3
Thowfeequ, S.4
Tosh, D.5
Carvalho, F.6
-
12
-
-
34247523321
-
Regulation of hepcidin in HepG2 and RINm5F cells
-
Fein E, Merle U, Ehehalt R, Herrmann T, Kulaksiz H. Regulation of hepcidin in HepG2 and RINm5F cells. Peptides. 2007;28(5):951-7. doi: 10.1016/j.peptides.2007.01.016.
-
(2007)
Peptides
, vol.28
, Issue.5
, pp. 951-957
-
-
Fein, E.1
Merle, U.2
Ehehalt, R.3
Herrmann, T.4
Kulaksiz, H.5
-
13
-
-
13544252463
-
Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia
-
Rivera S, Liu L, Nemeth E, Gabayan V, Sorensen OE, Ganz T. Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. Blood. 2005;105(4):1797-802. doi: 10.1182/blood-2004-08-3375.
-
(2005)
Blood
, vol.105
, Issue.4
, pp. 1797-1802
-
-
Rivera, S.1
Liu, L.2
Nemeth, E.3
Gabayan, V.4
Sorensen, O.E.5
Ganz, T.6
-
14
-
-
2342510407
-
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
-
Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113(9):1271-6. doi: 10.1172/jci20945.
-
(2004)
J Clin Invest
, vol.113
, Issue.9
, pp. 1271-1276
-
-
Nemeth, E.1
Rivera, S.2
Gabayan, V.3
Keller, C.4
Taudorf, S.5
Pedersen, B.K.6
-
15
-
-
34347219438
-
Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease
-
Kawabata H, Tomosugi N, Kanda J, Tanaka Y, Yoshizaki K, Uchiyama T. Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease. Haematologica. 2007;92(6):857-8.
-
(2007)
Haematologica
, vol.92
, Issue.6
, pp. 857-858
-
-
Kawabata, H.1
Tomosugi, N.2
Kanda, J.3
Tanaka, Y.4
Yoshizaki, K.5
Uchiyama, T.6
-
16
-
-
78149324897
-
Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease
-
Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, Yoshizaki K. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood. 2010;116(18):3627-34. doi: 10.1182/blood-2010-03-271791.
-
(2010)
Blood
, vol.116
, Issue.18
, pp. 3627-3634
-
-
Song, S.N.1
Tomosugi, N.2
Kawabata, H.3
Ishikawa, T.4
Nishikawa, T.5
Yoshizaki, K.6
-
17
-
-
66749095300
-
Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells
-
Mori K, Fujimoto-Ouchi K, Onuma E, Noguchi M, Shimonaka Y, Yasuno H, et al. Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells. Biomed Res. 2009;30(1):47-51.
-
(2009)
Biomed Res
, vol.30
, Issue.1
, pp. 47-51
-
-
Mori, K.1
Fujimoto-Ouchi, K.2
Onuma, E.3
Noguchi, M.4
Shimonaka, Y.5
Yasuno, H.6
-
18
-
-
22244464504
-
Parathyroid hormone-related protein (PTHrP) as a causative factor of cancer-associated wasting: possible involvement of PTHrP in the repression of locomotor activity in rats bearing human tumor xenografts
-
Onuma E, Tsunenari T, Saito H, Sato K, Yamada-Okabe H, Ogata E. Parathyroid hormone-related protein (PTHrP) as a causative factor of cancer-associated wasting: possible involvement of PTHrP in the repression of locomotor activity in rats bearing human tumor xenografts. Int J Cancer. 2005;116(3):471-8. doi: 10.1002/ijc.21038.
-
(2005)
Int J Cancer
, vol.116
, Issue.3
, pp. 471-478
-
-
Onuma, E.1
Tsunenari, T.2
Saito, H.3
Sato, K.4
Yamada-Okabe, H.5
Ogata, E.6
-
19
-
-
0037015958
-
Characterization of anti-mouse interleukin-6 receptor antibody
-
Okazaki M, Yamada Y, Nishimoto N, Yoshizaki K, Mihara M. Characterization of anti-mouse interleukin-6 receptor antibody. Immunol Lett. 2002;84(3):231-40.
-
(2002)
Immunol Lett
, vol.84
, Issue.3
, pp. 231-240
-
-
Okazaki, M.1
Yamada, Y.2
Nishimoto, N.3
Yoshizaki, K.4
Mihara, M.5
-
20
-
-
37649012006
-
Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up
-
Murao N, Ishigai M, Yasuno H, Shimonaka Y, Aso Y. Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Commun Mass Spectrom. 2007;21(24):4033-8. doi: 10.1002/rcm.3319.
-
(2007)
Rapid Commun Mass Spectrom
, vol.21
, Issue.24
, pp. 4033-4038
-
-
Murao, N.1
Ishigai, M.2
Yasuno, H.3
Shimonaka, Y.4
Aso, Y.5
-
21
-
-
84875253909
-
Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice
-
Sasaki Y, Noguchi-Sasaki M, Yasuno H, Yorozu K, Shimonaka Y. Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice. Int J Hematol. 2012;96(6):692-700. doi: 10.1007/s12185-012-1217-4.
-
(2012)
Int J Hematol
, vol.96
, Issue.6
, pp. 692-700
-
-
Sasaki, Y.1
Noguchi-Sasaki, M.2
Yasuno, H.3
Yorozu, K.4
Shimonaka, Y.5
-
22
-
-
84878470675
-
Iron refractory iron deficiency anemia
-
De Falco L, Sanchez M, Silvestri L, Kannengiesser C, Muckenthaler MU, Iolascon A, et al. Iron refractory iron deficiency anemia. Haematologica. 2013;98(6):845-53. doi: 10.3324/haematol.2012.075515.
-
(2013)
Haematologica
, vol.98
, Issue.6
, pp. 845-853
-
-
Falco, L.1
Sanchez, M.2
Silvestri, L.3
Kannengiesser, C.4
Muckenthaler, M.U.5
Iolascon, A.6
-
23
-
-
0345743620
-
IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system
-
Hagihara K, Nishikawa T, Isobe T, Song J, Sugamata Y, Yoshizaki K. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Biophys Res Commun. 2004;314(2):363-9.
-
(2004)
Biochem Biophys Res Commun
, vol.314
, Issue.2
, pp. 363-369
-
-
Hagihara, K.1
Nishikawa, T.2
Isobe, T.3
Song, J.4
Sugamata, Y.5
Yoshizaki, K.6
-
24
-
-
2342644926
-
Oxygen sensing by HIF hydroxylases
-
Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 2004;5(5):343-54. doi: 10.1038/nrm1366.
-
(2004)
Nat Rev Mol Cell Biol
, vol.5
, Issue.5
, pp. 343-354
-
-
Schofield, C.J.1
Ratcliffe, P.J.2
-
25
-
-
0032805582
-
Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis
-
Voulgari PV, Kolios G, Papadopoulos GK, Katsaraki A, Seferiadis K, Drosos AA. Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol. 1999;92(2):153-60. doi: 10.1006/clim.1999.4736.
-
(1999)
Clin Immunol
, vol.92
, Issue.2
, pp. 153-160
-
-
Voulgari, P.V.1
Kolios, G.2
Papadopoulos, G.K.3
Katsaraki, A.4
Seferiadis, K.5
Drosos, A.A.6
-
26
-
-
0030808921
-
Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease
-
Jongen-Lavrencic M, Peeters HR, Wognum A, Vreugdenhil G, Breedveld FC, Swaak AJ. Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease. J Rheumatol. 1997;24(8):1504-9.
-
(1997)
J Rheumatol
, vol.24
, Issue.8
, pp. 1504-1509
-
-
Jongen-Lavrencic, M.1
Peeters, H.R.2
Wognum, A.3
Vreugdenhil, G.4
Breedveld, F.C.5
Swaak, A.J.6
-
27
-
-
0028206058
-
Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritis
-
Tanabe M, Ochi T, Tomita T, Suzuki R, Sakata T, Shimaoka Y, et al. Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritis. J Rheumatol. 1994;21(5):830-5.
-
(1994)
J Rheumatol
, vol.21
, Issue.5
, pp. 830-835
-
-
Tanabe, M.1
Ochi, T.2
Tomita, T.3
Suzuki, R.4
Sakata, T.5
Shimaoka, Y.6
-
28
-
-
84891903512
-
Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells
-
McCranor BJ, Kim MJ, Cruz NM, Xue QL, Berger AE, Walston JD, et al. Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells. Blood Cells Mol Dis. 2014;52(2-3):126-33. doi: 10.1016/j.bcmd.2013.09.004.
-
(2014)
Blood Cells Mol Dis
, vol.52
, Issue.2-3
, pp. 126-133
-
-
McCranor, B.J.1
Kim, M.J.2
Cruz, N.M.3
Xue, Q.L.4
Berger, A.E.5
Walston, J.D.6
-
29
-
-
50349085287
-
Involvement of hepcidin in the anemia of multiple myeloma
-
Sharma S, Nemeth E, Chen YH, Goodnough J, Huston A, Roodman GD, et al. Involvement of hepcidin in the anemia of multiple myeloma. Clin Cancer Res. 2008;14(11):3262-7. doi: 10.1158/1078-0432.ccr-07-4153.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.11
, pp. 3262-3267
-
-
Sharma, S.1
Nemeth, E.2
Chen, Y.H.3
Goodnough, J.4
Huston, A.5
Roodman, G.D.6
-
30
-
-
84899802247
-
Mouse models of anemia of cancer
-
Kim A, Rivera S, Shprung D, Limbrick D, Gabayan V, Nemeth E, et al. Mouse models of anemia of cancer. PLoS One. 2014;9(3):e93283. doi: 10.1371/journal.pone.0093283.
-
(2014)
PLoS One
, vol.9
, Issue.3
, pp. e93283
-
-
Kim, A.1
Rivera, S.2
Shprung, D.3
Limbrick, D.4
Gabayan, V.5
Nemeth, E.6
-
31
-
-
33745742487
-
Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis
-
Vokurka M, Krijt J, Sulc K, Necas E. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res. 2006;55(6):667-74.
-
(2006)
Physiol Res
, vol.55
, Issue.6
, pp. 667-674
-
-
Vokurka, M.1
Krijt, J.2
Sulc, K.3
Necas, E.4
-
32
-
-
0028180987
-
The acute-phase protein alpha 1-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake
-
Graziadei I, Gaggl S, Kaserbacher R, Braunsteiner H, Vogel W. The acute-phase protein alpha 1-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake. Blood. 1994;83(1):260-8.
-
(1994)
Blood
, vol.83
, Issue.1
, pp. 260-268
-
-
Graziadei, I.1
Gaggl, S.2
Kaserbacher, R.3
Braunsteiner, H.4
Vogel, W.5
-
33
-
-
0037093202
-
Regulation of ferritin genes and protein
-
Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002;99(10):3505-16.
-
(2002)
Blood
, vol.99
, Issue.10
, pp. 3505-3516
-
-
Torti, F.M.1
Torti, S.V.2
-
34
-
-
84879952087
-
Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis
-
Shimamoto K, Ito T, Ozaki Y, Amuro H, Tanaka A, Nishizawa T, et al. Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis. J Rheumatol. 2013;40(7):1074-81. doi: 10.3899/jrheum.121389.
-
(2013)
J Rheumatol
, vol.40
, Issue.7
, pp. 1074-1081
-
-
Shimamoto, K.1
Ito, T.2
Ozaki, Y.3
Amuro, H.4
Tanaka, A.5
Nishizawa, T.6
-
35
-
-
58149154996
-
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
-
Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood. 2008;112(10):3959-64. doi: 10.1182/blood-2008-05-155846.
-
(2008)
Blood
, vol.112
, Issue.10
, pp. 3959-3964
-
-
Nishimoto, N.1
Terao, K.2
Mima, T.3
Nakahara, H.4
Takagi, N.5
Kakehi, T.6
-
36
-
-
0141504266
-
Iron deficiency and erythropoiesis: new diagnostic approaches
-
Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem. 2003;49(10):1573-8.
-
(2003)
Clin Chem
, vol.49
, Issue.10
, pp. 1573-1578
-
-
Brugnara, C.1
-
37
-
-
0027533103
-
Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects
-
Brugnara C, Chambers LA, Malynn E, Goldberg MA, Kruskall MS. Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood. 1993;81(4):956-64.
-
(1993)
Blood
, vol.81
, Issue.4
, pp. 956-964
-
-
Brugnara, C.1
Chambers, L.A.2
Malynn, E.3
Goldberg, M.A.4
Kruskall, M.S.5
-
38
-
-
84896491618
-
The IL-6 feed-forward loop: a driver of tumorigenesis
-
Chang Q, Daly L, Bromberg J. The IL-6 feed-forward loop: a driver of tumorigenesis. Semin Immunol. 2014;26(1):48-53. doi: 10.1016/j.smim.2014.01.007.
-
(2014)
Semin Immunol
, vol.26
, Issue.1
, pp. 48-53
-
-
Chang, Q.1
Daly, L.2
Bromberg, J.3
-
39
-
-
0028587318
-
Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding
-
Hammacher A, Ward LD, Weinstock J, Treutlein H, Yasukawa K, Simpson RJ. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding. Protein Sci. 1994;3(12):2280-93. doi: 10.1002/pro.5560031213.
-
(1994)
Protein Sci
, vol.3
, Issue.12
, pp. 2280-2293
-
-
Hammacher, A.1
Ward, L.D.2
Weinstock, J.3
Treutlein, H.4
Yasukawa, K.5
Simpson, R.J.6
-
40
-
-
84896495791
-
A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy
-
Tanaka T, Narazaki M, Ogata A, Kishimoto T. A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy. Semin Immunol. 2014;26(1):88-96. doi: 10.1016/j.smim.2014.01.009.
-
(2014)
Semin Immunol
, vol.26
, Issue.1
, pp. 88-96
-
-
Tanaka, T.1
Narazaki, M.2
Ogata, A.3
Kishimoto, T.4
-
41
-
-
84943791915
-
A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-alpha2b in patients with recurrent epithelial ovarian cancer
-
Dijkgraaf EM, Santegoets SJ, Reyners AK, Goedemans R, Wouters MC, Kenter GG, et al. A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-alpha2b in patients with recurrent epithelial ovarian cancer. Ann Oncol. 2015;26(10):2141-9. doi: 10.1093/annonc/mdv309.
-
(2015)
Ann Oncol
, vol.26
, Issue.10
, pp. 2141-2149
-
-
Dijkgraaf, E.M.1
Santegoets, S.J.2
Reyners, A.K.3
Goedemans, R.4
Wouters, M.C.5
Kenter, G.G.6
-
42
-
-
84875713812
-
Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia
-
Ando K, Takahashi F, Motojima S, Nakashima K, Kaneko N, Hoshi K, et al. Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia. J Clin Oncol. 2013;31(6):e69-72. doi: 10.1200/jco.2012.44.2020.
-
(2013)
J Clin Oncol
, vol.31
, Issue.6
, pp. e69-72
-
-
Ando, K.1
Takahashi, F.2
Motojima, S.3
Nakashima, K.4
Kaneko, N.5
Hoshi, K.6
-
43
-
-
84882451000
-
Favorable responses to tocilizumab in two patients with cancer-related cachexia
-
Hirata H, Tetsumoto S, Kijima T, Kida H, Kumagai T, Takahashi R, et al. Favorable responses to tocilizumab in two patients with cancer-related cachexia. J Pain Symptom Manage. 2013;46(2):e9-13. doi: 10.1016/j.jpainsymman.2013.01.009.
-
(2013)
J Pain Symptom Manage
, vol.46
, Issue.2
, pp. e9-13
-
-
Hirata, H.1
Tetsumoto, S.2
Kijima, T.3
Kida, H.4
Kumagai, T.5
Takahashi, R.6
-
44
-
-
84904184220
-
Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer
-
Ando K, Takahashi F, Kato M, Kaneko N, Doi T, Ohe Y, et al. Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer. PLoS One. 2014;9(7):e102436. doi: 10.1371/journal.pone.0102436.
-
(2014)
PLoS One
, vol.9
, Issue.7
-
-
Ando, K.1
Takahashi, F.2
Kato, M.3
Kaneko, N.4
Doi, T.5
Ohe, Y.6
|